PRE 14A XBRL

PRE 14A

Company: Processa Pharmaceuticals, Inc.
Filed: May 1, 2025
Period of Report: May 1, 2025
Accession Number: 0001641172-25-008097

View Document ↗ View on SEC.gov ↗